HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of adding calcitonin to physical treatment on reflex sympathetic dystrophy.

Abstract
The efficacy of intranasal salmon calcitonin was examined in a double-blind randomized study in reflex sympathetic dystrophy. Sixty-six patients were randomly divided in two groups receiving physiotherapy. In addition group I also received 3 x 100 U/day of salmon calcitonin by intranasal spray whereas group II received 3 sprays of placebo. The pain and the range of motion were improved by calcitonin administration. Similarly the patients' ability to work was also improved. The results confirmed that salmon calcitonin has an effect but that this effect was not equally observed on all parameters analyzed. It was most marked on pain (at rest and on movement) and on the ability to work.
AuthorsC Gobelet, M Waldburger, J L Meier
JournalPain (Pain) Vol. 48 Issue 2 Pg. 171-175 (Feb 1992) ISSN: 0304-3959 [Print] United States
PMID1589234 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Calcitonin
Topics
  • Administration, Intranasal
  • Adult
  • Calcitonin (administration & dosage, adverse effects, therapeutic use)
  • Combined Modality Therapy
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pain (drug therapy, physiopathology)
  • Pain Measurement
  • Physical Therapy Modalities
  • Reflex Sympathetic Dystrophy (physiopathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: